Establishment Labs Announces Japanese Regulatory Approval and Reimbursement for Motiva Implants and the Motiva Flora Tissue Expander for Use in Post-Mastectomy Reconstruction

SANTA BARBARA, Calif.--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated…

Contraline Announces First Patients Successfully Implanted in Male Contraceptive Study

Company raises $7.2M in funding led by GV to advance in-human clinical trials of the…

Lasik SMILE Eye Surgery in Dubai with the Zeiss Visumax 800

ZEISS SMILE is the gold standard in laser eye surgery as a non-invasive and painless…

World-Leading UAV Manufacturer Selects Gilat in Multi-Year, Multimillion-Dollar Strategic Agreement for UAV Terminals

Gilat's next generation satellite communication terminals to enable advanced capabilities in high/medium altitude, long-endurance unmanned…

Algoma Central Corporation and Furetank Double Investment in Product Tankers

Algoma and Furetank expand FureBear joint venture to construct four additional climate-friendly dual-fuel product tankers…

Algoma Central Corporation and Furetank Double Investment in Product Tankers

Algoma and Furetank expand FureBear joint venture to construct four additional climate-friendly dual-fuel product tankers…

Algoma Central Corporation and Furetank Double Investment in Product Tankers

Algoma and Furetank expand FureBear joint venture to construct four additional climate-friendly dual-fuel product tankers…

BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers

BRUKINSA now approved in Brazil for three indications CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING--(BUSINESS…

BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers

BRUKINSA now approved in Brazil for three indications CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING--(BUSINESS…

BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers

BRUKINSA now approved in Brazil for three indications CAMBRIDGE, Mass., & BASEL, Switzerland & BEIJING--(BUSINESS…